AdvisorNet Financial Inc Has $57,000 Position in UiPath Inc. (NYSE:PATH)

AdvisorNet Financial Inc grew its holdings in UiPath Inc. (NYSE:PATHGet Rating) by 48.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,120 shares of the healthcare company’s stock after purchasing an additional 1,020 shares during the quarter. AdvisorNet Financial Inc’s holdings in UiPath were worth $57,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in PATH. Private Advisor Group LLC acquired a new stake in shares of UiPath in the fourth quarter valued at about $372,000. Charles Schwab Investment Management Inc. grew its position in shares of UiPath by 3.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 756,868 shares of the healthcare company’s stock valued at $32,644,000 after purchasing an additional 25,532 shares during the last quarter. Geode Capital Management LLC grew its position in shares of UiPath by 4.4% in the fourth quarter. Geode Capital Management LLC now owns 2,164,082 shares of the healthcare company’s stock valued at $93,336,000 after purchasing an additional 90,485 shares during the last quarter. Gotham Asset Management LLC acquired a new stake in shares of UiPath in the fourth quarter valued at about $217,000. Finally, Rockefeller Capital Management L.P. grew its position in shares of UiPath by 132.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 6,688 shares of the healthcare company’s stock valued at $287,000 after purchasing an additional 3,816 shares during the last quarter. 51.35% of the stock is owned by institutional investors and hedge funds.

UiPath Trading Down 4.6 %

NYSE:PATH opened at $13.04 on Friday. UiPath Inc. has a 1 year low of $12.21 and a 1 year high of $59.57. The firm has a 50 day moving average of $17.67 and a 200-day moving average of $19.67. The stock has a market capitalization of $7.10 billion, a P/E ratio of -16.30 and a beta of 0.11.

UiPath (NYSE:PATHGet Rating) last posted its earnings results on Tuesday, September 6th. The healthcare company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.09. UiPath had a negative net margin of 42.98% and a negative return on equity of 19.19%. The company had revenue of $242.22 million during the quarter, compared to analysts’ expectations of $230.68 million. During the same quarter in the previous year, the company posted ($0.17) earnings per share. UiPath’s quarterly revenue was up 23.9% compared to the same quarter last year. As a group, analysts forecast that UiPath Inc. will post -0.63 EPS for the current fiscal year.

Insider Activity

In other news, CFO Ashim Gupta sold 100,000 shares of UiPath stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $20.70, for a total value of $2,070,000.00. Following the completion of the transaction, the chief financial officer now owns 1,387,266 shares in the company, valued at $28,716,406.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Hitesh Ramani sold 22,800 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $20.70, for a total value of $471,960.00. Following the completion of the transaction, the chief accounting officer now owns 426,799 shares in the company, valued at approximately $8,834,739.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ashim Gupta sold 100,000 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $20.70, for a total transaction of $2,070,000.00. Following the completion of the transaction, the chief financial officer now owns 1,387,266 shares of the company’s stock, valued at approximately $28,716,406.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 162,800 shares of company stock worth $3,129,960. Insiders own 31.88% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PATH. Morgan Stanley downgraded UiPath from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $32.00 to $15.00 in a research report on Wednesday, September 7th. Royal Bank of Canada decreased their target price on UiPath from $22.00 to $18.00 in a research report on Wednesday, September 7th. BMO Capital Markets decreased their target price on UiPath from $21.00 to $15.00 in a research report on Wednesday, September 7th. Wells Fargo & Company decreased their target price on UiPath from $30.00 to $22.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 7th. Finally, Evercore ISI decreased their target price on UiPath from $28.00 to $23.00 in a research report on Thursday, June 2nd. Seven research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.97.

UiPath Company Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHGet Rating).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.